Cardiovascular disease: risk assessment and reduction, including lipid modification
KEYWORDS: people, cvd, risk, treatment, statin, statins, committee, recommendations, prevention, evidence, cholesterol, recommendation, lipid-lowering, primary, amended

recommendations on communication in NICE's guidelines on patient experience in adult NHS services and shared decision making. [2014] 1.1.13 Set aside adequate time during the consultation to provide information on risk assessment and to answer any questions. Arrange for further consultation if needed. [2008, amended May 2023] 1.1.14 Document the discussion relating to the consultation on risk assessment and the person's decision. [2008] 1.1.15 Offer people information about their absolute risk of CVD and the absolute benefits and harms of any intervention over a 10-year period. [2008] 1.1.16 Consider using a lifetime risk tool such as QRISK3-lifetime to inform discussions on CVD risk and to motivate lifestyle changes, particularly for people with a 10-year QRISK3 score less than 10%, and people under 40 who have CVD risk factors. [May 2023] 1.1.17 To encourage the person to participate in reducing their CVD risk: • find out what, if anything, the person has already been told about their CVD risk and how they feel about it • explore the person's beliefs about what determines future health (this may affect their attitude to changing risk) • assess their readiness to make changes to their lifestyle (diet, physical activity, smoking and alcohol consumption), to
